Measuring indirect transmission-reducing effects in tuberculosis vaccine efficacy trials: why and how?Friday, August 9, 2024Availability, Epidemiological impactRead More
ACEITar: Evaluation of the acceptability of new and repurposed tuberculosis vaccines in Mozambique Friday, August 9, 2024Acceptability, Acceptability and demandRead More
Impact and cost-effectiveness of new tuberculosis vaccines in low- and middle-income countries.Friday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Age-targeted tuberculosis vaccination in China and implications for vaccine development: a modelling study.Friday, August 9, 2024Availability, Epidemiological impactRead More
Feasibility of novel adult tuberculosis vaccination in South Africa: a cost-effectiveness and budget impact analysis.Friday, August 9, 2024Availability, Economic impact/cost-effectivenss, Implementation strategies and feasibilityRead More
Potential impact of tuberculosis vaccines in China, South Africa, and IndiaFriday, August 9, 2024Availability, Epidemiological impactRead More
Impact of targeted tuberculosis vaccination among a mining population in South Africa: A model based studyFriday, August 9, 2024Availability, Epidemiological impactRead More
Potential impact of spatially targeted adult tuberculosis vaccine in Gujarat, IndiaFriday, August 9, 2024Availability, Epidemiological impactRead More
The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug resistant tuberculosis in India and ChinaFriday, August 9, 2024Availability, Economic impact/cost-effectivenss, Epidemiological impactRead More
Epidemiological impact of targeted interventions for people with diabetes mellitus on tuberculosis transmission in India: Modelling based predictionsFriday, August 9, 2024Availability, Epidemiological impactRead More
